New Zealand family seeking cannabinoid spray prescription say many more could benefit

Pharmac plans to discuss Sativex with its primary clinical advisory committee this month, a first step towards possibly more public funding. Photo / Thinkstock

For 11 years, Jacinta Newport's daughter has been in pain.

Sometimes in the hips, sometimes in her lower limbs, that pain, along with frequent visits to specialists, has been a constant, just like her cocktail of medicines and often terrible side effects.

"It's just affected her life on every level," Mrs Newport says.

Her daughter, now 22, was diagnosed with juvenile arthritis when she was 11. The condition affects about one in 1000 New Zealand children.

"We've tried everything. We've been everywhere. We know what works and what doesn't work."

Mrs Newport, a nurse, said her daughter had worked hard to complete her education and lead a social life, despite side-effects from opioid medicines including drowsiness, fatigue, dry mouth, blurred vision and hyperalgesia, or heightened sensitivity...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=11490218